The lymphocyte transformation test with type II collagen as a diagnostic tool of autoimmune sensorineural hearing

P Berger1, M Hillman, M Tabak

  • 1Hals-Nasen-Ohrenklinik, Medizinische Hochschule Hannover, Germany.

The Laryngoscope
|August 1, 1991
PubMed

Insights

The lymphocyte transformation test (LTT) can diagnose autoimmune hearing loss. Using type II collagen as an antigen, this study found a significant immune response in patients with progressive sensorineural hearing loss (PSNHL).

Area of Science:

  • Immunology
  • Otolaryngology
  • Rheumatology

Background:

  • Cellular immunological disorders are diagnosed using the lymphocyte transformation test (LTT).
  • Autoimmune mechanisms in sensorineural hearing loss (SNHL) can be assessed using inner ear tissue as an antigen.
  • Type II collagen is implicated in rheumatoid diseases and autoimmune SNHL.

Purpose of the Study:

  • To evaluate the role of type II collagen in autoimmune SNHL.
  • To assess immune responses in patients with progressive sensorineural hearing loss (PSNHL) using LTT.

Main Methods:

  • Conducted the lymphocyte transformation test (LTT) on 68 patients with PSNHL and 68 healthy volunteers.
  • Utilized type II collagen as the specific antigen for the LTT.

Main Results:

  • Thirty-four out of 68 PSNHL patients exhibited a strong positive LTT response to type II collagen.
  • Only four out of 68 healthy volunteers showed a positive LTT response, with two having a history of rheumatoid arthritis.

Conclusions:

  • Type II collagen may serve as an autoantigen in a subset of patients with progressive sensorineural hearing loss.
  • LTT with type II collagen shows potential for diagnosing autoimmune mechanisms in PSNHL.

Related Concept Videos